COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,749 Articles (22,502 medRxiv, 8,247 bioRxiv)

Most recent first Previous |  Page 242: Articles 2411-2420  | Next

Virological characteristics of the SARS-CoV-2 JN.1 variant
Kaku, Y., Okumura, K., Padilla-Blanco, M., Kosugi, Y., Uriu, K., Hinay, A. A., Chen, L., Plianchaisuk, A., Kobiyama, K., Ishii, K. J., The Genotype to Phenotype Japan (G2P-Japan) Consortium, , Zahradnik, J., Ito, J., Sato, K.
10.1101/2023.12.08.570782 — Posted: 2023-12-09
Lack of association between HLA and asymptomatic SARS-CoV-2 infection
Marchal, A., Cirulli, E. T., Neveux, I., Bellos, E., Thwaites, R. S., Schiabor Barrett, K. M., Zhang, Y., Nemes-Bokun, I., Kalinova, M., Catchpole, A., Tangye, S. G., Spaan, A. N., Lack, J. B., Ghosn, J., Burdet, C., Gorochov, G., Tubach, F., Hausfater, P., COVID Human Genetic Effort, , COVIDeF Study Group, , French COVID Cohort Study Group, , CoV-Contact Cohort, , COVID-STORM Clinicians, , COVID Clinicians, , Orchestra Working Group, , Amsterdam UMC Covid-19 Biobank, , NIAID-USUHS COVID Study Group, , Dalgard, C. L., Zhang, S.-Y., Zhang, Q., Chiu, C., Fellay, J., Grzymski, J. J., San
10.1101/2023.12.06.23299623 — Posted: 2023-12-08
Fungal pleural infection due to Microascus gracilis with pulmonary aspergillosis after COVID-19 pneumonia
Hu, Z., Mao, L., Deng, T., Su, B., Yang, Y., Dong, B., Xu, Q., Yang, S.
10.1101/2023.12.07.23298951 — Posted: 2023-12-08
Investigating the Determinants of COVID-19 Vaccine Uptake and Attitudes in Iraq: A Study Unveiling the Negative Impact of Misinformation and Vaccine Conspiracy
Sallam, M., Kareem, N., Alkurtas, M.
10.1101/2023.12.06.23299628 — Posted: 2023-12-08
SARS-CoV-2 infection is associated with intestinal permeability, systemic inflammation, and microbial dysbiosis in hospitalized COVID-19 patients
Basting, C. M., Langat, R., Broedlow, C. A., Guerrero, C., Bold, T. D., Bailey, M., Velez, A., Schroeder, T., Short-Miller, J., Cromarty, R., Mayer, Z., Southern, P. J., Schacker, T. W., Safo, S. E., Bramante, C. T., Tignanelli, C. J., Schifanella, L., Klatt, N. R.
10.1101/2023.12.07.570670 — Posted: 2023-12-08
Infection Control Program Among the Ysleta del Sur Pueblo Prevents Hospitalizations and Deaths During the Covid-19 Pandemic
Torres, C. M., Aparicio, V., Morales, G., Mena, A., Spencer, C. T.
10.1101/2023.12.05.23299531 — Posted: 2023-12-07
Impact of COVID-19 on mental illness in vaccinated and unvaccinated people: a population-based cohort study in OpenSAFELY
Walker, V., Patalay, P., Cuitin Coronado, J. I., Denholm, R., Forbes, H., Stafford, J., Moltrecht, B., Palmer, T., Walker, A., Thompson, E. J., Taylor, K., Cezard, G., Horne, E. M., Wei, Y., Al Arab, M., Knight, R., Fisher, L., Massey, J., Davy, S., Mehrkar, A., Bacon, S., Goldacre, B., Wood, A., Chaturvedi, N., Macleod, J., John, A., Sterne, J. A.
10.1101/2023.12.06.23299602 — Posted: 2023-12-07
The impact of Long COVID on Health-Related Quality-of-life using OpenPROMPT
Carlile, O., Briggs, A., Henderson, A., Butler-Cole, B., Tazare, J., Tomlinson, L., Marks, M., Jit, M., Lin, L.-Y., Bates, C., Parry, J., Bacon, S., Dillingham, I., Dennison, W., Costello, R., Walker, A., Hulme, W. J., Goldacre, B., Mehrkar, A., MacKenna, B., The OpenSAFELY Collaborative, , Herrett, E., Eggo, R.
10.1101/2023.12.06.23299601 — Posted: 2023-12-07
SARS-CoV-2 Humoral Immune Responses in Convalescent Individuals Over 12 Months Reveal Severity-Dependent Antibody Dynamics
Schuler, M., Siles, N., Maguire, C., Amengor, D., Nguyen, A., Wilen, R., Rogers, J., Bazzi, S., Caslin, B., DiPasquale, C., Abigania, M., Olson, E., Creaturo, J., Hurley, K., Triplett, T. A., Rousseau, J. F., Strakowski, S. M., Wylie, D., Maynard, J., Ehrlich, L. I. R., Melamed, E.
10.1101/2023.12.05.23299462 — Posted: 2023-12-07
In Silico Therapeutic Intervention on Cytokine Storm in COVID-19
Bakshi, A., Gangopadhyay, K., Basak, S., Chakrabarti, A., Dasgupta, A., De, R. K.
10.1101/2023.12.05.570280 — Posted: 2023-12-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).